Bayer can still be saved from $66 bln splurge

September 14, 2016

The agreed takeover of U.S. rival Monsanto is too expensive. The German group's investors have probably lost $7 bln in value already. The question is whether antitrust regulators do what shareholders can't and nix the tie-up. Paying the $2 bln break fee would still be preferable.

Fertilizer duo bucks trend with $36 bln love-in

September 12, 2016

Canada's Potash and Agrium are combining in a merger of equals. It's a contrast to past industry mash-up attempts, which gave off a whiff of exuberance before collapsing. There's plenty for both sets of shareholders to like, assuming the deal clears antitrust hurdles.

Potash giant emerges from ashes of failed deals

August 30, 2016

Canadian fertilizer companies Agrium and Potash Corp of Saskatchewan said on Aug. 30 they were in preliminary discussions about a merger of equals. Potash shares were up about 11 percent and Agrium's 6 percent at 1 p.m. EDT. The talks were first reported by Bloomberg.

from Viewsroom:

Viewsroom: India water woes; fintech; Trumponomics

August 12, 2016

Drought, farmers, poor pricing and bad infrastructure in the world's second-most populous country hinder Prime Minister Narendra Modi's 'Make in India' vision; peer-to-peer lenders try to deal with a downturn; and Donald Trump's economic plan is more pinstripes than blue collar.

Monsanto may be overestimating independence

July 19, 2016

The U.S. crop giant rejected Bayer's latest $64 bln takeover offer, calling it "financially inadequate." To achieve the $125 a share on offer on its own over three years would be tough, however, even with aggressive assumptions. Monsanto boss Hugh Grant is protesting too much.

Bayer’s Monsanto bid flags conglomerate curse

May 23, 2016

The German group can only muster a $62 bln swoop on the U.S. seed maker because of its big healthcare arm. Without that, Bayer’s crop science unit would be prey not predator. The bidder’s management may see this as a perk of being diversified. For shareholders it’s the opposite.

BASF best leaving Monsanto seeds for the birds

May 19, 2016

Bayer’s bid for the U.S. seed maker puts its German rival on the spot. Monsanto and BASF work together on research and there are few other potential merger partners. Yet the maths of a $50 bln-plus counterbid would be a stretch. BASF has sat out other big deals; it can again.

Bayer would risk choking on Monsanto

May 12, 2016

The $94 bln German chemical giant may be mulling a bid for the U.S. seed maker. Monsanto, worth $39 bln, would need convincing. A deal pitched at a 30 pct premium is financially feasible, but Bayer would need to raise a lot of cash – and deal with clashing cultures.

Dow-DuPont deal would be tough nut for interlopers

March 7, 2016

German chemical giant BASF may be considering a counterbid for U.S. rival DuPont. The price would have to include a whopping premium – and cover a $1.9 bln break fee. The tax benefits alone could make the agreed-upon $130 bln union and spinoff with Dow Chemical close to ironclad.

ChemChina can reap rewards of new stance on GMOs

February 4, 2016

Buying Syngenta will thaw China’s hostility towards genetically modified organisms. Nationalist fears about food safety will ring hollow once the seeds are in Chinese hands. The buyer will be able to push into a huge new market – but so, in time, will rivals like Monsanto.